Cushing's Hub

A resource for healthcare professionals caring for patients with Cushing’s syndrome

This editorial looks at highly important yet non-routine aspects of Cushing’s syndrome and encourages readers to consider aspects of the disease where literature is scarce. Topics include once-in-a-lifetime events necessitating hospitalization – sometimes before diagnosis is made – and practical advice on the use of steroidogenesis inhibitors. The editorial also highlights recent research on the effect of Cushing’s syndrome on pregnancy outcomes.
Latest from across Cushing's Hub
September 2, 2021

The selective glucocorticoid receptor modulator relacorilant may warrant further investigation for the treatment of endogenous Cushing’s syndrome, suggest phase 2 trial results published in Frontiers in Endocrinology in July 2021.

August 3, 2021

The 37th Congress of the Société Française d’Endocrinologie – the French Society of Endocrinology – will be held in Le Havre in October 2021.

Case Study
July 21, 2021

The second interactive case study explores the management of relapsing Cushing’s disease in a woman of childbearing age with emphasis given to pregnancy planning.

From the Editorial Board: Welcome to Cushing’s Hub

“A website on Cushing’s syndrome? Why would I be interested in a website like that?”
The Editorial Board Members describe the importance of a website dedicated to Cushing’s syndrome and the reasons they signed up for the project.